A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines

A multivalent, rapidly deployable, mucosal vaccine platform is desperately needed to prevent acquisition and transmission of respiratory infections during epidemics and pandemics. No such approved platform currently exists and virtually all under investigation use infectious viruses that have safety...

Full description

Bibliographic Details

Published in:	Small Science
Main Authors:	Jingen Zhu, Jian Sha, Himanshu Batra, Swati Jain, Xiaorong Wu, Emily K. Hendrix, Paul B. Kilgore, Keer Sun, Kenneth S. Plante, Jessica A. Plante, Jordyn Walker, Pan Tao, Ashok K. Chopra, Venigalla B. Rao
Format:	Article
Language:	English
Published:	Wiley-VCH 2025-04-01
Subjects:	bacteriophage bacteriophage‐based vaccine influenza multivalent antigen presentation non‐infectious mucosal vaccine SARS‐CoV‐2
Online Access:	https://doi.org/10.1002/smsc.202400580